Varespladib Sodium

**Semantic type:** Pharmacologic Substance

**Definition:** An intravenously administered inhibitor of secretory phospholipase A2 (sPLA2) with orphan drug designation. Varespladib is in trial for prevention of Acute Chest Syndrome in the treatment of sickle cell disease.

**Synonyms:** - ((3-(Aminooxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic Acid - A-001 - VARESPLADIB SODIUM